ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025
Sharp increase in Chlamydia pneumoniae infections in 2024 in Germany.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Spread ofEmerging microbes & infections · 2026Article
- Upsurge of Chlamydia pneumoniae respiratory tract infections in 2024/2025 in Southern Germany.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Clinical features and chest CT findings ofFrontiers in medicine · 2026Article
- Machine learning-based identification of inflammatory biomarkers for predicting pulmonary consolidation in children with Chlamydia pneumoniae infection.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chlamydia pneumoniae (C. pneumoniae) is a recognized cause of respiratory infections in children and adolescents, while it is often considered a negligible pathogen in adults outside of outbreaks. We performed a retrospective analysis from a nationwide surveillance network in Germany that collected data from 2018 to 2024. A multivariate analysis (binomial model) was performed to assess the influence of year, hospitalization status, gender and age on C. pneumoniae detection rate. Our analysis showed an increasing C. pneumoniae detection rate in 2024 compared to 2019, especially in children below 15 years and adults aged 30-50 years, mostly in patients who were treated as outpatients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.